Delivery Order SPE2DR25D2005-SPE2DR26FF0D7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,710.68 to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 7, 2026, for the supply of Zepbound 10 mg/0.5 mL pens. This competitive, firm fixed-price delivery order is scheduled for ultimate completion on January 8, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 ml pens on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply services under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $4,058.35 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pens on December 4, 2025, with completion expected by December 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $14,518.84 delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pens on July 15, 2025, with completion scheduled for July 16, 2025. This competitive award carries firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $5,537.14 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pens on December 12, 2025, with an ultimate completion date of December 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pens on June 23, 2025, with a ceiling value of $14,598.18 and a firm fixed price structure. This delivery order represents a non-set-aside, competitively awarded contract for pharmaceutical procurement, with an ultimate completion date of June 24, 2025. The award was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $12,285.20 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on a firm fixed-price basis. The delivery order, issued on December 29, 2025, with an ultimate completion date of December 30, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This competitive award involved no set-aside designation and will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Zepbound 10 mg/0.5 mL pens valued at $4,810.62. This is a firm fixed-price delivery order with an ultimate completion date of October 23, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $3,250.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pens (0.5 mL) with an ultimate completion date of June 2, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. The pharmaceutical distributor, headquartered...
- The Defense Logistics Agency awarded a $30,444.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 ml pens on November 18, 2025, with completion scheduled for November 19, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement valued through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FF0D7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,018.20 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pens on January 6, 2026, with an ultimate completion date of January 7, 2026. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with Cencora, Inc. (doing business as AmerisourceBergen) as its parent organization. This delivery order operates under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which provides the overarching vehicle for pharmaceutical and medical supply procurement to support military healthcare programs globally. The delivery order represents a routine pharmaceutical procurement for Zepbound, a diabetes medication, reflecting the Defense Logistics Agency's ongoing medical supply chain operations. AmerisourceBergen's extensive portfolio of federal contracts demonstrates its established capability as a critical pharmaceutical distributor for military and veteran healthcare systems, delivering a comprehensive range of brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. This contract award exemplifies the company's role as a primary vendor supporting the Defense Health Agency and other government healthcare systems through flexible and competitive procurement mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 1/5/26 |